BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
50 auth. L. Piccoli, Young-Jun Park, M. A. Tortorici, N. Czudnochowski, A. Walls, M. Beltramello, C. Silacci-Fregni, D. Pinto, Laura E. Rosen, John E. Bowen, O. Acton, S. Jaconi, B. Guarino, A. Minola, F. Zatta, ... Nicole Sprugasci, J. Bassi, A. Peter, A. De Marco, J. Nix, F. Mele, S. Jovic, Blanca M. Fernandez Rodriguez, Sneha V. Gupta, Feng Jin, G. Piumatti, G. Lo Presti, A. F. Pellanda, M. Biggiogero, M. Tarkowski, M. Pizzuto, E. Cameroni, C. Havenar-Daughton, M. Smithey, David Hong, Valentino Lepori, E. Albanese, A. Ceschi, E. Bernasconi, L. Elzi, P. Ferrari, C. Garzoni, A. Riva, G. Snell, F. Sallusto, K. Fink, H. Virgin, A. Lanzavecchia, D. Corti, D. Veesler
10 2020
10
🐜
🐜 Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.
23 auth. R. Lapalombella, Qingxiang Sun, Katie E. Williams, Larissa Tangeman, S. Jha, Y. Zhong, V. Goettl, Emilia Mahoney, C. Berglund, Sneha V. Gupta, ... Alicia Farmer, R. Mani, A. Johnson, D. Lucas, X. Mo, D. Daelemans, V. Sandanayaka, S. Shechter, D. McCauley, S. Shacham, M. Kauffman, Y. Chook, J. Byrd
8 2012
8
🐜
🐜 Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
12 auth. Natasha Strydom, Sneha V. Gupta, William S Fox, L. Via, Hye-lim Bang, Myung‐hee Lee, ... S. Eum, T. Shim, C. Barry, M. Zimmerman, V. Dartois, R. Savic
7 2019
7
🐜
🐜 ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.
18 auth. Emilia Mahoney, D. Lucas, Sneha V. Gupta, Amy J. Wagner, S. E. Herman, Lisa L. Smith, Yuh-Ying Yeh, L. Andritsos, Jeffrey A Jones, J. Flynn, ... K. Blum, Xiaoli Zhang, A. Lehman, H. Kong, M. Gurcan, M. Grever, A. Johnson, J. Byrd
6 2012
6
🐜
🐜 The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells
12 auth. A. Johnson, Yuh-Ying Yeh, Lisa L. Smith, Amy J. Wagner, J. Hessler, Sneha V. Gupta, ... J. Flynn, Jeffrey A Jones, Xiaoli Zhang, R. Bannerji, M. Grever, J. Byrd
6 2012
6
🐜
🐬 Determining the Time Window for Dynamic Nanowire Cell Penetration Processes.
Xi Xie, Amin Aalipour, Sneha V. Gupta, N. Melosh
6 2015
6
🐬
🦁 Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells
16 auth. Sneha V. Gupta, E. Sass, Melanie E. Davis, Ryan B. Edwards, G. Lozanski, N. Heerema, A. Lehman, Xiaoli Zhang, D. Jarjoura, John C. Byrd, ... Li Pan, Kenneth K. Chan, A. Kinghorn, M. Phelps, M. Grever, D. Lucas
6 2011
6
🦁
🐜 Characterization of Silvestrol Pharmacokinetics in Mice Using Liquid Chromatography–Tandem Mass Spectrometry
14 auth. U. Saradhi, Sneha V. Gupta, Ming Chiu, Jiang Wang, Yonghua Ling, Zhongfa Liu, D. Newman, J. Covey, A. Kinghorn, G. Marcucci, ... D. Lucas, M. Grever, M. Phelps, K. Chan
5 2011
5
🐜
🦁 The Proteasome Inhibitor Carfilzomib Functions Independently of p53 to Induce Cytotoxicity and an Atypical NF-κB Response in Chronic Lymphocytic Leukemia Cells
12 auth. Sneha V. Gupta, E. Hertlein, Yanhui Lu, E. Sass, R. Lapalombella, Timothy L. Chen, ... Melanie E. Davis, J. Woyach, A. Lehman, D. Jarjoura, J. Byrd, D. Lucas
5 2013
5
🦁
🦁 Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
9 auth. Sneha V. Gupta, M. Fanget, Christopher Maclauchlin, Valerie A. Clausen, Jing Li, Daniel J. Cloutier, ... Ling Shen, G. Robbie, E. Mogalian
4 2021
4
🦁
🐜 Potentiating Effect of the Flavonolignan (‐)‐Hydnocarpin in Combination with Vincristine in a Sensitive and P‐gp‐Expressing Acute Lymphoblastic Leukemia Cell Line
7 auth. Lynette Bueno Pérez, Li Pan, E. Sass, Sneha V. Gupta, A. Lehman, A. Kinghorn, ... D. Lucas
4 2013
4
🐜